MétaCan
Menu
← Back to cohort
Record W4416139978 · doi:10.1093/neuonc/noaf201.1530

QOL-29. Evaluating the effectiveness of a tailored exercise intervention on neuro-oncology patient outcomes

2025· article· en· W4416139978 on OpenAlexaffabout
Julia T. Daun, Löw J, L Capozzi, Tana Dhruva, Gloria Roldan Urgoiti, Meghan H. McDonough, J. Easaw, Margaret L. McNeely, George J. Francis, Tanya Williamson, Jessica Danyluk, Emma McLaughlin, Paula A. Ospina, Christine Lesiuk, Paula de Robles, Catriona Leckie, Allan S. Brett, S. Nicole Culos‐Reed

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicCancer survivorship and care
Canadian institutionsCanadian Patient Safety InstituteAlberta Health ServicesKelowna General HospitalUniversity of AlbertaUniversity of Calgary
Fundersnot available
KeywordsIntervention (counseling)Quality of life (healthcare)Aerobic exerciseCoachingHealth coachingPhysical activityRandomized controlled trialMinimal clinically important differencePsychological intervention

Abstract

fetched live from OpenAlex

Abstract Despite the known benefits of exercise as a supportive cancer care resource, evidence of its effectiveness in neuro-oncology is scarce and thus access to programming remains limited. This study evaluated the effectiveness of a tailored neuro-oncology exercise intervention on patient outcomes – the Alberta Cancer Exercise-Neuro Oncology (i.e., ACE-Neuro) study. ACE-Neuro was a multi-site type II effectiveness-implementation trial delivered in Alberta, Canada and included a 12-week tailored exercise and health coaching intervention to adult neuro-oncology patients. Measures included baseline and 12-week patient-reported outcomes and functional fitness, acute energy and fatigue assessed pre-/post-exercise sessions, and objective physical activity assessed across the intervention via a Garmin activity tracker. Descriptive statistics and linear mixed models were used to analyze the data. Across a 20-month recruitment period, n=62 participants were scheduled to begin the intervention, and n=51 completed (82.3%). Statistically significant improvements were observed for overall quality of life (p < 0.011) and the sub-domains of functional well-being (p < 0.018) and brain-specific concerns (p < 0.001). Resistance exercise levels (p < 0.005), balance (p < 0.009 right side and p < 0.002 left side), and aerobic fitness (p < 0.001) also significantly improved. General fatigue worsened from pre- to post-intervention (p < 0.048). Acute energy significantly worsened after each exercise session (p = 0.001) but significantly improved from baseline to 12-weeks (p < 0.001), while acute fatigue significantly improved across the intervention (p < 0.001). Objective physical activity during the intervention averaged 86.6 ± 57.51 minutes per day. ACE-Neuro was associated with improved patient-reported, functional fitness, and objective physical activity outcomes, contributing to the limited literature on exercise interventions in neuro-oncology. Ongoing work is needed to continue to tailor and deliver effective exercise interventions that meet the unique needs of this patient population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.030

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.369
Teacher spread0.341 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueNeuro-Oncology→Same topicCancer survivorship and care→French-language works237,207→